These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 4418784

  • 21. [Does multiple use of a cuprophan dialyser influence levels of chromium and cadmium during hemodialysis in patients with chronic kidney failure?].
    Małecka J, Grzeszczak W, Zukowska-Szczechowska E, Jendryczko A, Baczyński R.
    Pol Arch Med Wewn; 1995 Dec; 94(6):482-7. PubMed ID: 8618810
    [Abstract] [Full Text] [Related]

  • 22. [Acute effects of hemodialysis on circulating parathormone, osteocalcin and alkaline phosphatase in patients with chronic renal failure].
    Broulík P, Hrubý M.
    Cas Lek Cesk; 1993 Nov 22; 132(22):681-3. PubMed ID: 8293434
    [Abstract] [Full Text] [Related]

  • 23. Serum and urinary lysozyme activities in patients with renal diseases.
    Niwa T, Ito T, Matsui E, Ota H.
    Tohoku J Exp Med; 1974 Sep 22; 114(1):27-33. PubMed ID: 4432241
    [No Abstract] [Full Text] [Related]

  • 24. [Study of renal function in renal insufficiency. I. Renal function of the patients under chronic hemodialysis].
    Kawamura J, Okabe T, Yamashita A, Sawanishi K, Katõ T.
    Hinyokika Kiyo; 1971 Mar 22; 17(3):157-86. PubMed ID: 5103947
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Red-cell calcium in patients with renal failure.
    Barton IK, Mansell MA, Grimes AJ.
    Nephron; 1987 Mar 22; 47(2):123-4. PubMed ID: 3696316
    [Abstract] [Full Text] [Related]

  • 27. Metabolomic analysis of human plasma from haemodialysis patients.
    Sato E, Kohno M, Yamamoto M, Fujisawa T, Fujiwara K, Tanaka N.
    Eur J Clin Invest; 2011 Mar 22; 41(3):241-55. PubMed ID: 20955218
    [Abstract] [Full Text] [Related]

  • 28. The exposure to cadmium, lead and mercury from smoking and its impact on renal integrity.
    Mortada WI, Sobh MA, El-Defrawy MM.
    Med Sci Monit; 2004 Mar 22; 10(3):CR112-6. PubMed ID: 14976454
    [Abstract] [Full Text] [Related]

  • 29. Cadmium exposure in tobacco workers: possible renal effects.
    Sişman AR, Bülbül M, Coker C, Onvural B.
    J Trace Elem Med Biol; 2003 Mar 22; 17(1):51-5. PubMed ID: 12755502
    [Abstract] [Full Text] [Related]

  • 30. The use of sulphadimidine (sulphamezathine) in patients with renal failure.
    Adam WR, Brown DJ, Hales P, Dawborn JK.
    Med J Aust; 1973 May 12; 1(19):936-8. PubMed ID: 4715400
    [No Abstract] [Full Text] [Related]

  • 31. Alkaline phosphatase activity in leukocytes of patients with renal failure treated with dialyses.
    Kuska J.
    Pol Med J; 1971 May 12; 10(3):570-6. PubMed ID: 5124125
    [No Abstract] [Full Text] [Related]

  • 32. Study of the activity of erythrocyte acid phosphatase in chronic renal failure.
    Melissinos K, Vlassopoulos K, Drivas G, Kourounis G.
    Clin Chim Acta; 1973 Jan 24; 43(2):195-9. PubMed ID: 4265808
    [No Abstract] [Full Text] [Related]

  • 33. [Free erythropoietic protoporphyrins in chronic renal insufficiency].
    Tabernero Romo JM, Rodríguez Commes JL, Macias Núñez JF, Bondia Roman A, Corbacho Becerra L, Juanes González A, de Castro del Pozo S.
    Rev Clin Esp; 1978 Jul 24; 150(1-2):31-4. PubMed ID: 704989
    [No Abstract] [Full Text] [Related]

  • 34. The effect of low magnesium dialysate on plasma, ultrafiltrable, erythrocyte and bone magnesium concentrations from patients on maintenance haemodialysis.
    Catto GR, Reid IW, MacLeod M.
    Nephron; 1974 Jul 24; 13(5):372-81. PubMed ID: 4431548
    [No Abstract] [Full Text] [Related]

  • 35. [Biochemical changes in patients with chronic renal insufficiency during hemodialysis depending on whether or not they received 25-(OH)D3].
    Rico H, Naranjo P, Paniagua MC, Cordero M, Bordiu E, Charro A.
    Rev Clin Esp; 1982 Oct 15; 167(1):45-7. PubMed ID: 7178586
    [No Abstract] [Full Text] [Related]

  • 36. The relevance of urea kinetic modeling to CAPD.
    Lysaght MJ, Pollock CA, Hallet MD, Ibels LS, Farrell PC.
    ASAIO Trans; 1989 Oct 15; 35(4):784-90. PubMed ID: 2611047
    [No Abstract] [Full Text] [Related]

  • 37. [Correction of the composition of the dialyzing solution during its electrochemical regeneration].
    Maksimov EP, Leshchinskiĭ GM, Grinval'd VM, Fomicheva NN, Shadiev BSh.
    Med Tekh; 2003 Oct 15; (2):8-10. PubMed ID: 12924213
    [Abstract] [Full Text] [Related]

  • 38. Which dialyser?
    Kerr DN, Hoenich NA, Frost TH, Clayton CB, Jolly D.
    Nephron; 1974 Oct 15; 12(5):368-92. PubMed ID: 4824047
    [No Abstract] [Full Text] [Related]

  • 39. Conjugation of aromatic amines in renal failure.
    Young DS, Wootton ID.
    Clin Chim Acta; 1968 Nov 15; 22(3):403-8. PubMed ID: 5696964
    [No Abstract] [Full Text] [Related]

  • 40. Plasma, red cell and cerebrospinal fluid concentrations of myoinositol in patients with severe chronic renal failure.
    Servo C, Bardy A, Pasternack A, Pitkänen E.
    Ann Clin Res; 1976 Dec 15; 8(6):374-7. PubMed ID: 1008476
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.